Dazodalibep
Horizon Therapeutics
['dazodalibep']
dazodalibep is the next cd40l inhibitor being tested in sjogren s - we need better therapies genuinely reducing symptom burden. nice phase 2 data analyses so far of subjective measures, and plenty will be happy if we see this kind of result in phase 3 lb0003 #eular2023 
Rheumatologist and clinical pharmacologist, world traveller pretences on the upswing, sometimes journal podcast host. All opinions my own